Early predictors of intensive care unit admission among COVID-19 patients in Qatar

Front Public Health. 2024 Mar 20:12:1278046. doi: 10.3389/fpubh.2024.1278046. eCollection 2024.

Abstract

Background: COVID-19 is associated with significant morbidity and mortality. This study aimed to explore the early predictors of intensive care unit (ICU) admission among patients with COVID-19.

Methods: This was a case-control study of adult patients with confirmed COVID-19. Cases were defined as patients admitted to ICU during the period February 29-May 29, 2020. For each case enrolled, one control was matched by age and gender.

Results: A total of 1,560 patients with confirmed COVID-19 were included. Each group included 780 patients with a predominant male gender (89.7%) and a median age of 49 years (interquartile range = 18). Predictors independently associated with ICU admission were cardiovascular disease (adjusted odds ratio (aOR) = 1.64, 95% confidence interval (CI): 1.16-2.32, p = 0.005), diabetes (aOR = 1.52, 95% CI: 1.08-2.13, p = 0.016), obesity (aOR = 1.46, 95% CI: 1.03-2.08, p = 0.034), lymphopenia (aOR = 2.69, 95% CI: 1.80-4.02, p < 0.001), high AST (aOR = 2.59, 95% CI: 1.53-4.36, p < 0.001), high ferritin (aOR = 1.96, 95% CI: 1.40-2.74, p < 0.001), high CRP (aOR = 4.09, 95% CI: 2.81-5.96, p < 0.001), and dyspnea (aOR = 2.50, 95% CI: 1.77-3.54, p < 0.001).

Conclusion: Having cardiovascular disease, diabetes, obesity, lymphopenia, dyspnea, and increased AST, ferritin, and CRP were independent predictors for ICU admission in patients with COVID-19.

Keywords: COVID-19; critically ill patients; intensive care unit; mortality; predictors; risk factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • COVID-19* / epidemiology
  • Cardiovascular Diseases*
  • Case-Control Studies
  • Diabetes Mellitus*
  • Dyspnea
  • Ferritins
  • Humans
  • Intensive Care Units
  • Lymphopenia*
  • Male
  • Middle Aged
  • Obesity
  • Qatar / epidemiology
  • Risk Factors

Substances

  • Ferritins

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was supported by Hamad Medical Corporation (grant number: MRC-05-025).